Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial
Endry H. T. Lim(Amsterdam Neuroscience), Rutger Koning(Amsterdam University Medical Centers), Matthijs C. Brouwer(University of Amsterdam), Sabine Hermans, Vanessa Harris(Amsterdam UMC Location University of Amsterdam), Janneke Horn(Amsterdam University Medical Centers), Martijn Beudel(Amsterdam Neuroscience), Michiel A. van Agtmael, Romein W. G. Dujardin(Amsterdam University Medical Centers), Armand R. J. Girbes(University of Amsterdam), Peter I. Bonta, Marije K. Bomers, Brent Appelman(Amsterdam University Medical Centers), Marianna Bugiani(Amsterdam University Medical Centers), Anna Geke Algera, Lucas M. Fleuren(Erasmus MC), Anita M. Tuip‐de Boer(Amsterdam University Medical Centers), Maria Habel(Inflarx (Germany)), Maurits C. F. J. de Rotte(Erasmus MC), Lieuwe D. J. Bos(Amsterdam Neuroscience), Leo Heunks(Radboud University Nijmegen), Harm Jan Bogaard(Amsterdam UMC Location Vrije Universiteit Amsterdam), Esther Bulle(Amsterdam University Medical Centers), Lonneke A. van Vught(University of Amsterdam), Jörg Hamann(Netherlands Institute for Neuroscience), Laura A. Hagens(Utah College of Applied Technology), Michela Botta(Amsterdam University Medical Centers), Paul Elbers(Vrije Universiteit Amsterdam), Alex Cloherty(Amsterdam University Medical Centers), Zhongli Xu(Inflarx (Germany)), Justin de Brabander, Markus W. Hollmann(European Society of Anaesthesiology), Alexander P. J. Vlaar(University of Amsterdam), Mirjam Dijkstra(Amsterdam University Medical Centers), Menno D. de Jong(National Institute for Public Health and the Environment), Osoul Chouchane(Amsterdam Neuroscience), Robert Hemke(Amsterdam University Medical Centers), Suzanne E. Geerlings(Amsterdam University Medical Centers), Dave A. Dongelmans(Amsterdam UMC Location University of Amsterdam), Sanne de Bruin(Amsterdam University Medical Centers), Martin P. Grobusch(University of Amsterdam), Diederik van de Beek(University of Amsterdam), Godelieve de Bree(Amsterdam Institute for Global Health and Development), Joppe W. Hovius(Geneeskundige en Gezondheidsdienst), Floor van Baarle, David T.P. Buis(Amsterdam University Medical Centers)
Cited by 18
Related Papers
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
|Clinical Microbiology Reviews|2010|922